Transcriptional activation of the estrogen receptor

• Published in: Clinical chemistry (Baltimore, Md.) Vol. 39; no. 2; pp. 341 - 345
• Main Author: Wei, LL
• Format: Journal Article
• Language: English
• Published: England Am Assoc Clin Chem 01.02.1993
• Subjects: Amino Acid Sequence; Base Sequence; Breast Neoplasms - genetics; Breast Neoplasms - metabolism; DNA - metabolism; Estrogens - pharmacology; Humans; Molecular Sequence Data; Mutation; Receptors, Estrogen - chemistry; Receptors, Estrogen - genetics; Receptors, Estrogen - metabolism; Transcription, Genetic
• ISSN: 0009-9147; 1530-8561
• DOI: 10.1093/clinchem/39.2.341

Almost all breast cancer tumors progress to a hormone-resistant state. Evidence is presented that the existence of mutant estrogen receptors may explain some hormone-resistant phenotypes. Breast tumor cells bearing a mutant receptor that is constitutively active and does not bind hormone would have unregulated cell growth and thus appear to be hormone-independent. Alternatively, breast cancer cells may contain estrogen receptors that are transcriptionally inactive but when co-expressed with wild-type receptors render normal estrogen receptors inactive. These cells would be considered estrogen receptor-positive but would be hormone-resistant. The hormone-resistant phenotype could be further complicated by the finding that other nonreceptor proteins may also modulate the transcriptional activity of estrogen receptors. These findings, if substantiated in vivo, could add to the complexity of the hormone-resistant phenotype. Different strategies of treatment will need to be developed to effectively treat the various subtypes of hormone-resistant breast tumors.